PRINTER'S NO. 452
No. 26 Session of 2001
INTRODUCED BY MOWERY, ARMSTRONG, BOSCOLA, BRIGHTBILL, O'PAKE, STOUT, WAGNER, SCHWARTZ, THOMPSON, TILGHMAN, TOMLINSON, LOGAN, MURPHY, MUSTO, GREENLEAF, EARLL, GERLACH AND KASUNIC, FEBRUARY 13, 2001
INTRODUCED AND ADOPTED, FEBRUARY 13, 2001
A RESOLUTION 1 Designating March 6, 2001, as "Lymphedema D-Day" in 2 Pennsylvania. 3 WHEREAS, Lymphedema is an accumulation of lymphatic fluid 4 that causes swelling in the arms, legs or other areas of the 5 body and affects both men and women; and 6 WHEREAS, The swelling caused by lymphedema can lead to severe 7 infection or loss of the use of limbs, and patients suffering 8 from lymphedemas must endure physical discomfort and 9 disfigurement and cope with the distress caused by these 10 symptoms; and 11 WHEREAS, The single largest group of people who get 12 lymphedema are cancer patients, including breast, prostate, 13 gynecological, head, neck, lung, sarcoma and melanoma patients; 14 and 15 WHEREAS, Recent studies have indicated that 20% of breast 16 cancer patients will get lymphedema after surgery and radiation; 17 and
1 WHEREAS, According to the National Cancer Institute, there 2 are a reported 8.5 million Americans living after a diagnosis of 3 cancer, of which about 2 million are breast cancer survivors; 4 and 5 WHEREAS, No drug or effective surgical treatment for 6 lymphedema currently exists; and 7 WHEREAS, Research in all areas of lymphedema has been notably 8 limited; and 9 WHEREAS, Lymphedema, which has no cure and can occur anytime, 10 has a severe financial, physical and psychological impact on 11 patients; and 12 WHEREAS, Each year on March 6, the National Lymphedema 13 Network sponsors "Lymphedema D-Day" to honor patients and to 14 raise awareness of the treatment and severity of this condition; 15 therefore be it 16 RESOLVED, That the Senate designate March 6, 2001, as 17 "Lymphedema D-Day" in Pennsylvania; and be it further 18 RESOLVED, That the Senate encourage the citizens of this 19 Commonwealth to honor and support the courageous patients living 20 and coping with this debilitating condition. A25L82JS/20010S0026R0452 - 2 -